MickieHsiao MeiChengMDPhD

Diabetes, Lipid Metabolism

Adjunct Associate Professor, Diabetes Center, UCSF School of Medicine

Dr. Cheng is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
MarinHealth Endocrine & Diabetes Care | A UCSF Health Clinic
900 S Eliseo Dr, Suite 201
Greenbrae, CA 94904
Phone+1 415-461-1780

Fax+1 415-461-7378

University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 2004 - 2009
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2002 - 2004
University of Texas Southwestern Medical SchoolClass of 2002

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

PubMed

Publisher Correction: Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Jeremy Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey
Nature Medicine. 2023-11-01
22 citations
Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.
Caleigh Mandel-Brehm, Sara E Vazquez, Christopher Liverman, Mickie Cheng, Zoe Quandt
Diabetes. 2023-01-01
27 citations
Glucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.
Jeremy Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey
Nature Medicine. 2022-10-01

Journal Articles

Antigen Identification In A Novel Model Of Spontaneous Autoimmune Ovarian DiseaseEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2011